Q1 2025 Definitive Healthcare Corp Earnings Call Transcript
Key Points
- Definitive Healthcare Corp (DH) exceeded its guidance range on both the top and bottom lines for Q1 2025.
- Adjusted EBITDA was $14.7 million, representing a 25% margin, which was well ahead of expectations.
- The company saw strong double-digit growth in the number of engagements where they integrated their data with clients' systems.
- New logo activity was solid across all end markets, indicating ongoing demand for their differentiated data.
- Definitive Healthcare Corp (DH) is making progress on its strategic priorities, including data quality, seamless integration, customer success, and digital engagement.
- Total revenue for Q1 2025 was $59.2 million, down 7% year-over-year.
- Retention rates remain lower than desired, impacting subscription revenue.
- Adjusted gross profit was down 11% from Q1 2024, with a decrease in gross profit margin.
- Sales and marketing expenses as a percentage of revenue increased by 220 basis points year-over-year.
- The company is facing pressures on renewals, which continue to impact subscription revenues.
Welcome to Definitive Healthcare's Q1 2025 earnings call. Later, we will conduct a question-and-answer session. I would now like to turn the call over to your host. You may begin.
Good afternoon. Thank you for joining us today to review Definitive Healthcare's financial results. Joining me on the call today are Kevin Coop, our Chief Executive Officer; Rick Booth, our CFO; and Casey Heller, SVP of Finance.
During this call, we will make forward-looking statements, including, but not limited to, statements related to our market future performance and growth opportunities, the benefits of our differentiated data and health care commercial intelligence solutions, our competitive position, customer behaviors and use of our solutions, customer growth, our financial guidance, our planned investments and operational strategy, generating value for our customers and shareholders, the anticipated impacts of global macroeconomic conditions on our business results and customers and on the health care industry generally and on
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
